This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

FINAL SAVINGS ENG IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dr. Patrick Baeuerle, PhD
Chief Scientific Advisor at Cullinan Therapeutics
Speaker

Profile

Biography of Presenter:

  • Co-founder, Chief Scientific Advisor and Chairman of the Scientific Advisory Board of Cullinan Therapeutics
  • Honorary Professor of Immunology at the Institute for Immunology, Ludwig Maximilian University (LMU), Munich
  • As former Executive Partner of MPM Capital, the co-founder of eight biotech companies in the US and Europe: Harpoon, Maverick, Werewolf, TCR2, Aktis, Crossbow, iOmx and Cullinan
  • Leadership roles in Drug Discovery at Tularik, Micromet, Amgen, Harpoon, Maverick, Crossbow and Cullinan
  • Formerly Professor and Chairman of Biochemistry and Molecular Biology at the University of Freiburg, School of Medicine
  • Formerly Group Leader at the Gene Center, MPI for Biochemistry, Martinsried
  • Postdoctorate at the Whitehead Institute/MIT with Dr. David Baltimore, Cambridge
  • Study of biochemistry at the universities of Konstanz and Munich

Agenda Sessions

  • Cullinan's T Cell Engaging Antibody Construct CLN-978 for Treatment of Autoimmune Disease

    11:30